Intra-articular Platelet-rich plasma for Hip Osteoarthritis in Kochi medical school

Intra-articular Platelet-rich plasma for Hip Osteoarthritis in Kochi medical school - IPHOK study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTb060190038

Enrollment

Registered

2020-03-11

Start date

2019-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the hip

Interventions

The patients are performed drawing blood of 90 ml in both groups.The Citramin Solution are mixed as blood clotting inhibitor for one syringe of 50 ml. (1)Intra-articular 1ml of platelet-rich plasma an

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 20 years or older women younger than 80 years To satisfy standards determined by ACR clinical classification criteria for osteoarthritis of the hip Kellgren and Lawrence grade 1-3 with radiographs

Exclusion criteria

Exclusion criteria: post operative cases rheumatoid Arthritis cases osteonecrosis cases Blood coagulation disorder cases Impossible to evaluate of patients-based outcome BMI is more than 30 No consent is obtained

Design outcomes

Primary

Measure	Time frame
Rate of change of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) -Pain	—

Secondary

Measure	Time frame
Pain VAS WOMAC-Stiffness WOMAC-Physical Function Japanese Orthopaedic Association hip score and Harris hip score Japanese Orthopaedic Association Hip-Disease Evaluation Questionnaire Harris Hip Score Oxford Hip Score Use of pain-killer frequency CTX-2 MRI	—

Countries

Japan

Contacts

Public ContactYusuke Okanoe

Kochi Medical School Hospital

im35@kochi-u.ac.jp+81-88-880-2386

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026